Drug resistance markers for surveillance in schistosomiasis control programs
Principal Investigator(s)
Anderson, Timothy
Funded by
Bill & Melinda Gates Foundation
Research Start Date
Status
Active
The current program to control and eliminate schistosomiasis is based on mass chemotherapy with praziquantel (PZQ). The success of this campaign is dependent on the continued effectiveness of this drug. Development of widespread PZQ resistance would severely impede these programs, so it is critical that we develop tools for determining the level of resistance in treated populations, which is the goal of this study.